Grant opportunity
MRC Early Independence: Clinician Scientist Fellowship
Early independence fellowship for clinician scientists; opened 10 June 2026.
- Funder
- UKRI / MRC
- 2 September 2026
- 2 September 2026: Sep 2, 2026
- Award
- Fellowship support
- Applicant
- Clinician scientists
- Discipline
- Health and Biomedical Sciences
- Region
- United Kingdom
- Posted
- Jun 10, 2026
Call summary
Overview
MRC Early Independence: Clinician Scientist Fellowship is a fellowship from UKRI / MRC. Early independence fellowship for clinician scientists; opened 10 June 2026.
Who can apply
Clinician scientists
What it supports
- Health and Biomedical Sciences
- United Kingdom
- Fellowship
Funding and duration
- Fellowship support
2 September 2026
2 September 2026: Sep 2, 2026
How to apply
Use the linked official source page to confirm the full call text, eligibility rules, required documents, deadline and submission route before applying.
Call details
Source-based overview
Early independence fellowship for clinician scientists; opened 10 June 2026. The funder or organiser is UKRI / MRC. The stated region or country focus is United Kingdom. The target applicants are Clinician scientists. The deadline or key date recorded for this call is 2 September 2026. Applicants should verify eligibility, funding rules, required documents and submission instructions on the official source page.
Eligibility
Clinician scientists
Funding and benefits
Fellowship support
Themes and supported activities
Health and Biomedical Sciences
United Kingdom
Fellowship
Deadline and timeline
2 September 2026: 2 September 2026: Sep 2, 2026.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Use the linked official source page to confirm the full call text, eligibility rules, required documents, deadline and submission route before applying.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.